- Home
- NKTR vs PTA Comparison
NKTR vs PTA Comparison
Compare NKTR & PTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKTR
- PTA
- Stock Information
- Founded
- NKTR 1990
- PTA 2020
- Country
- NKTR United States
- PTA United States
- Employees
- NKTR N/A
- PTA N/A
- Industry
- NKTR Biotechnology: Pharmaceutical Preparations
- PTA Trusts Except Educational Religious and Charitable
- Sector
- NKTR Health Care
- PTA Finance
- Exchange
- NKTR Nasdaq
- PTA Nasdaq
- Market Cap
- NKTR 1.2B
- PTA 1.2B
- IPO Year
- NKTR 1994
- PTA N/A
- Fundamental
- Price
- NKTR $57.96
- PTA $20.46
- Analyst Decision
- NKTR Strong Buy
- PTA
- Analyst Count
- NKTR 6
- PTA 0
- Target Price
- NKTR $91.67
- PTA N/A
- AVG Volume (30 Days)
- NKTR 1.2M
- PTA 159.2K
- Earning Date
- NKTR 11-06-2025
- PTA 01-01-0001
- Dividend Yield
- NKTR N/A
- PTA 8.31%
- EPS Growth
- NKTR N/A
- PTA N/A
- EPS
- NKTR N/A
- PTA N/A
- Revenue
- NKTR $74,934,000.00
- PTA N/A
- Revenue This Year
- NKTR N/A
- PTA N/A
- Revenue Next Year
- NKTR N/A
- PTA N/A
- P/E Ratio
- NKTR N/A
- PTA N/A
- Revenue Growth
- NKTR N/A
- PTA N/A
- 52 Week Low
- NKTR $6.48
- PTA $15.84
- 52 Week High
- NKTR $62.95
- PTA $19.67
- Technical
- Relative Strength Index (RSI)
- NKTR 65.18
- PTA 50.78
- Support Level
- NKTR $57.50
- PTA $20.38
- Resistance Level
- NKTR $62.82
- PTA $20.70
- Average True Range (ATR)
- NKTR 3.73
- PTA 0.25
- MACD
- NKTR -0.77
- PTA -0.04
- Stochastic Oscillator
- NKTR 56.85
- PTA 18.50
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.
About PTA Cohen & Steers Tax-Advantaged Preferred Securities and Income Fund of Beneficial Interest
COHEN & STEERS TAX-ADV PRD SEC AND INC is a non-diversified, closed-end management statutory trust. Its primary investment objective is high current income, and the Fund's secondary investment objective is capital appreciation.